Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 1, 2003, Pages 453-463

  De Luca, Annamaria ^a   Pierno, Sabata ^a   Liantonio, Antonella ^a   Cetrone, Michela ^a   Camerino, Claudia ^a   Fraysse, Bodvael ^a   Mirabella, Massimo ^b   Servidei, Serenella ^b   Rüegg, Urs T ^c   Conte Camerino, Diana ^a  

^a UNIVERSITY OF BARI   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CREATINE; METHYLPREDNISOLONE; RECOMBINANT SOMATOMEDIN C; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLORIDE CONDUCTANCE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DUCHENNE MUSCULAR DYSTROPHY; EXCITATION CONTRACTION COUPLING; EXTENSOR DIGITORUM LONGUS MUSCLE; FORELIMB; MALE; MUSCLE REGENERATION; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; PRIORITY JOURNAL; TREADMILL EXERCISE;

ANIMALS; CREATINE; DISEASE PROGRESSION; ELECTROPHYSIOLOGY; INSULIN-LIKE GROWTH FACTOR I; ION CHANNELS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE CONTRACTION; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; PATCH-CLAMP TECHNIQUES; PHYSICAL CONDITIONING, ANIMAL; TAURINE;

EID: 0037215644     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.041343     Document Type: Article

References (40)

1. Alderton JM and Steinhardt RA (2000) How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc Med 10:268-272.
2. Anderson JE, Weber M, and Vargas C (2000) Deflazacort increases laminin expression and myogenic repair and induces early persistent functional gain in mdx muscular dystrophy. Cell Transplant 9:551-564.
3. Barton ER, Morris L, Musaro A, Rosenthal N, and Sweeney HL (2002) Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157:137-147.
4. Blake DJ, Weir A, Newey SE, and Davies KE (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82:291-329.
5. Booth FW and Thomason DB (1991) Molecular and cellular adaptation of muscle in response to exercise: Perspectives of various models. Physiol Rev 71:541-585.
6. De Luca A, Pierno S, Camerino C, Cocchi D, and Conte Camerino D (1999) Higher content of insulin-like growth factor-I in dystrophic mdx mouse: Potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function. Neuromuscul Disord 9:11-18.
7. - conductance of rat skeletal muscle. Eur J Pharmacol 296:215-222.
8. De Luca A, Pierno S, and Conte Camerino D (1997) Electrical properties of diaphragm and EDL muscles during the life of dystrophic mice. Am J Physiol 272: C333-C340.
9. De Luca A, Pierno S, Liantonio A, Camerino C, and Conte Camerino D (1998) Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels. Br J Pharmacol 125:477-482.
10. De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Simonetti S, Papadia F, and Conte Camerino D (2001) Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine. Br J Pharmacol 132:1047-1054.
11. Dubowitz V (2002) Therapeutic possibilities in muscular dystrophy: The hope versus the hype. Neuromuscul Disord 12:113-116.
12. Dupont-Versteegden EE, McCarter RJ, and Katz MS (1994) Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice. J Appl Physiol 77:1736-1741.
13. Granchelli JA, Pollina C, and Hudecki MS (2000) Preclinical screening of drugs using the mdx mouse. Neuromuscul Disord 10:235-239.
14. Hayes A and Williams DA (1998) Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice. Am J Physiol 274:C1138-C1144.
15. Huxtable R (1992) Physiological actions of taurine. Physiol Rev 72:101-163.
16. Hoffman EP and Dressman D (2001) Molecular pathophysiology and targeted therapeutics for muscular dystrophy. Trends Pharmacol Sci 22:465-470.
17. Kanayama A, Inoue J, Sugita-Konishi Y, Shimizu M, and Miyamoto Y (2002) Oxidation of IκBα at methionine 45 is one cause of taurine-chloramine-induced inhibition of NFκB activation. J Biol Chem 277:24049-24056.
18. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, and Beal MF (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5:347-350.
19. Klocke R, Steinmeyer K, Jentsch TJ, and Jockusch H (1994) Role of innervation, excitability and myogenic factors in the expression of the muscular chloride channel ClC-1. A study on normal and myotonic muscle. J Biol Chem 269:27635-27639.
20. Kontny E, Szczepanska K, Kowalczewski J, Kurowska M, Janicka I, Marcinkiewicz J, and Maslinski W (2000) The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 43:2169-2177.
21. Matsuzaki Y, Miyazaki T, Miyakawa S, Bouscarel B, Ikegami T, and Tanaka N (2002) Decreased taurine concentration in skeletal muscles after exercise for various durations. Med Sci Sports Exerc 34:793-797.
22. McIntosh L, Granberg K-E, Brière KM, and Anderson JE (1998) Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: Correlation with repair. NMR Biomed 1:1-10.
23. Mitsui T, Azuma H, Nagasawa M, Iuchi T, Akaike M, Odomi M, and Matsumoto T (2002) Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle. J Neurol 249:1004-1009.
24. Mokhatarian A, Lefaucheur JP, Even PC, and Sebille A (1999) Hindlimb immobilization applied to 21-day-old mdx mice prevents the occurrence of muscle degeneration. J Appl Physiol 6:924-931.
25. Nakamura A, Yoshida K, Takeda S, Dohi N, and Ikeda S (2002) Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice. FEBS Lett 520:18-24.
26. Passaquin AC, Renard M, Kay L, Challet C, Mokhtarian A, Wallimann T, and Ruegg UT (2002) Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscul Disord 12:174-182.
27. Passaquin AC, Lhote P, and Rüegg UT (1998) Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Br J Pharmacol 124:1751-1759.
28. Petrof BJ, Stedman HH, Shrager JB, Eby J, Sweeney HL, and Kelly AM (1993) Adaptation in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. Am J Physiol 265:C834-C841.
29. Pierno S, Desaphy JF, Liantonio A, De Bellis M, Bianco G, De Luca A, Frigeri A, Nicchia GP, Svelto M, Léoty C, et al. (2002) Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse. Brain 125:1510-1521.
30. Pons S and Torres-Aleman I (2000) Insulin-like growth factor-I stimulates dephosphorylation of IkB through the serine phosphatase calcineurin (protein phosphatase 2B). J Biol Chem 275:38620-38625.
31. Porreca E, Guglielmi MD, Uncini A, Di Gregorio P, Angelini A, Di Febbo C, Pierdomenico SD, Baccante G, and Cuccurullo F (1999) Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. Thromb Haemost 81:543-546.
32. Porter JD, Khanna S, Kaminski HJ, Roa JS, Merriam AP, Richmonds CR, Leahy P, Li J, Guo W, and Andrade FH (2002) A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 11:263-272.
33. 2+ handling and survival in mdx skeletal muscle cells. FEBS Lett 439:357-362.
34. Sander M, Chavoshan B, Harris SA, Iannaccone ST, Stull JT, Thomas GD, and Victor RG (2000) Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci USA 97:13818-13823.
35. Sandri M, Podhorska-Okolow M, Geromel V, Rizzi C, Arslan P, Franceschi C, and Carraro U (1997) Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice. J Neuropathol Exp Neurol 56:45-57.
36. 2+-dependent calcineurin signaling pathway. Nature (Lond) 400:576-581.
37. Spencer MJ, Marino MW, and Winckler WM (2000) Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice. Neuromuscul Disord 10:612-619.
38. Tarnopolsky MS and Beal MF (2001) Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol 49: 561-574.
39. Vilquin J-T, Brussee V, Asselin I, Kinoshita I, Gingras M, and Tremblay JP (1998) Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve 21:567-576.
40. Wu H and Olson EN (2002) Activation of the MEF2 transcription factor in skeletal muscles from myotonic mice. J Clin Invest 109:1327-1333.